Pharming Group N.V. ADS each representing 10 ordinary shares (PHAR)
Stock · NASDAQ · Health Care
$11.7as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$12.91
Industry
Biotechnology: Pharmaceutical Preparations
About PHAR
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniol…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 407
- Website
- www.pharming.com/
Fundamentals
- 1-day range
- $11.68$12.05
- Market cap
- $766.28M
- P/E (trailing)
- 88.15
- P/E (forward)
- 38.60
- EPS (trailing)
- $0.02
- Dividend yield
- —
- Beta
- 0.20
- Avg. volume
- 13.0K
52-week range
$0.8338$1.82
Next earnings: July 30, 2026 · EPS estimate $0.06confirmed
Forecasts
4 analyst ratings
Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$39
+233.3%
Median
$37.5
+220.5%
Low
$23.4
+100.0%
Pharming Group N.V. ADS each representing 10 ordinary shares Competitors
Chosen by industry and closest market cap.
- PHARPharming Group N.V. ADS each representing 10 ordinary shares$11.7▼ 0.68%Market cap $766.28MP/E 88.15$0.8338$1.82
- CYRXCryoPort Inc. Common Stock$16.08▼ 2.96%Market cap $741.42MP/E —$7.61$17.2
- DRUGBright Minds Biosciences Inc. Common Stock$72.74▼ 2.41%Market cap $792.81MP/E —$53.99$170
- CTMXCytomX Therapeutics Inc. Common Stock$3.22▼ 5.99%Market cap $733.66MP/E —$1.9$8.21
- CLYMClimb Bio Inc. Common Stock$14.56▼ 3.32%Market cap $801.68MP/E —$1.54$18.33
- MNPRMonopar Therapeutics Inc. Common Stock$112.17▼ 1.55%Market cap $805.29MP/E —$32.77$124.82
- EVOEvotec SE American Depositary Shares$1.91▼ 2.80%Market cap $693.72MP/E —$3.18$7.3
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PHAR Pharming Group N.V. ADS each representing 10 ordinary shares | $766.28M | 88.15 | $11.7 | ▼ 0.68% | $0.8338$1.82 |
| CYRX CryoPort Inc. Common Stock | $741.42M | — | $16.08 | ▼ 2.96% | $7.61$17.2 |
| DRUG Bright Minds Biosciences Inc. Common Stock | $792.81M | — | $72.74 | ▼ 2.41% | $53.99$170 |
| CTMX CytomX Therapeutics Inc. Common Stock | $733.66M | — | $3.22 | ▼ 5.99% | $1.9$8.21 |
| CLYM Climb Bio Inc. Common Stock | $801.68M | — | $14.56 | ▼ 3.32% | $1.54$18.33 |
| MNPR Monopar Therapeutics Inc. Common Stock | $805.29M | — | $112.17 | ▼ 1.55% | $32.77$124.82 |
| EVO Evotec SE American Depositary Shares | $693.72M | — | $1.91 | ▼ 2.80% | $3.18$7.3 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Form 8.3Yahoo · 8/14/2026
- Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and olderYahoo · 8/13/2026
- Pharming Launches Joenja (Leniolisib) in Japan for APDS Patients Aged 4 and Older, Marking First Global Launch for Children 4 To 11Benzinga · 8/13/2026
- Pharming Group to participate in Canaccord Genuity 46th Annual Growth ConferenceYahoo · 8/4/2026
- Canaccord Genuity Maintains Buy on Pharming, Raises Price Target to $38Benzinga · 8/3/2026
- Pharming Group (ENXTAM:PHARM) Could Be 63% Undervalued After Guidance Cut And Half Year ResultsYahoo · 8/3/2026
- Form 8.3Yahoo · 7/31/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 82.8K
- Total value held
- $1.38M
- Institutional holders
- 11
Top holders this quarter
- Unknown44.7K
- Unknown11.5K
- Unknown10.8K
- Unknown10.2K
- Unknown4.1K
- Unknown557
- Unknown400
- Unknown343
- Unknown128
- Unknown79
See the full, filterable feed with live charts on the MarketWall dashboard.